{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:43:02Z","timestamp":1773956582964,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/jhg.2015.119","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T06:21:35Z","timestamp":1444285295000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genetics of hereditary large vessel diseases"],"prefix":"10.1038","volume":"61","author":[{"given":"Takayuki","family":"Morisaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"BFjhg2015119_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nature10145","volume":"473","author":"ME Lindsay","year":"2011","unstructured":"Lindsay, M. E. & Dietz, H. C. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 473, 308\u2013316 (2011).","journal-title":"Nature"},{"key":"BFjhg2015119_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0025-6196(11)60566-1","volume":"84","author":"VS Ramanath","year":"2009","unstructured":"Ramanath, V. S., Oh, J. K., Sundt, T. M. 3rd & Eagle, K. A. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin. Proc. 84, 465\u2013481 (2009).","journal-title":"Mayo Clin. Proc."},{"key":"BFjhg2015119_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/oxfordjournals.aje.a010245","volume":"151","author":"JF Blanchard","year":"2000","unstructured":"Blanchard, J. F., Armenian, H. K. & Friesen, P. P. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am. J. Epidemiol. 151, 575\u2013583 (2000).","journal-title":"Am. J. Epidemiol."},{"key":"BFjhg2015119_CR4","first-page":"220","volume":"13","author":"AB Marfan","year":"1896","unstructured":"Marfan, A. B. Un cas de deformation congenitale des quatre membres, plus prononcee aux extremites, caracterisee par l'allongement des os avec un certain degre d'amincissement. Bull. Mem. Soc. Med. Hop. Paris 13, 220\u2013226 (1896).","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"key":"BFjhg2015119_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1056\/NEJM197904053001406","volume":"300","author":"RE Pyeritz","year":"1979","unstructured":"Pyeritz, R. E. & McKusick, V. A. The Marfan syndrome. N. Engl. J. Med. 300, 772\u2013777 (1979).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg2015119_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ajmg.1320290316","volume":"29","author":"P Beighton","year":"1988","unstructured":"Beighton, P., De Paepe, A., Danks, D., Finidori, G., Gedde-Dahl, T., Goodman, R. et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am. J. Med. Genet. 29, 581\u2013594 (1988).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2015119_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","volume":"62","author":"A De Paepe","year":"1996","unstructured":"De Paepe, A., Devereux, R. B., Dietz, H. C., Hennekam, R. C. M. & Pyeritz, R. E. Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Genet. 62, 417\u2013426 (1996).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2015119_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys, B. L., Dietz, H. C., Braverman, A. C., Callewaert, B. L., De Backer, J., Devereux, R. B. et al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet 47, 476\u2013485 (2010).","journal-title":"J. Med. Genet"},{"key":"BFjhg2015119_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1242\/jcs.00229","volume":"116","author":"JP Annes","year":"2003","unstructured":"Annes, J. P., Munger, J. S. & Rifkin, D. B. Making sense of latent TGF\u03b2 activation. J. Cell Sci. 116, 217\u2013224 (2003).","journal-title":"J. Cell Sci."},{"key":"BFjhg2015119_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke, P. & Arthur, H. M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 8, 857\u2013869 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFjhg2015119_CR11","first-page":"662","volume":"49","author":"K Kainulainen","year":"1991","unstructured":"Kainulainen, K., Steinmann, B., Collins, F., Dietz, H. C., Francomano, C. A., Child, A. et al. Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am. J. Hum. Genet. 49, 662\u2013667 (1991).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2015119_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz, H. C., Cutting, G. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 337\u2013339 (1991).","journal-title":"Nature"},{"key":"BFjhg2015119_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ajmg.1320580216","volume":"58","author":"T Aoyama","year":"1995","unstructured":"Aoyama, T., Francke, U., Gasner, C. & Furthmayr, H. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Am. J. Med. Genet. 58, 169\u2013176 (1995).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2015119_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/520125","volume":"81","author":"L Faivre","year":"2007","unstructured":"Faivre, L., Collod-Beroud, G., Loeys, B. L., Child, A., Binquet, C., Gautier, E. et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am. J. Hum. Genet. 81, 454\u2013466 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2015119_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1172\/JCI200420641","volume":"114","author":"DP Judge","year":"2004","unstructured":"Judge, D. P., Biery, N. J., Keene, D. R., Geubtner, J., Myers, L., Huso, D. L. et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J. Clin. Invest. 114, 172\u2013181 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFjhg2015119_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1056\/NEJMoa055695","volume":"355","author":"BL Loeys","year":"2006","unstructured":"Loeys, BL, Schwarze, U, Holm, T, Callewaert, BL, Thomas, GH, Pannu, H et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N. Engl. J. Med. 355, 788\u2013798 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg2015119_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet 37, 275\u2013281 (2005).","journal-title":"Nat. Genet"},{"key":"BFjhg2015119_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ng1392","volume":"36","author":"T Mizuguchi","year":"2004","unstructured":"Mizuguchi, T., Collod-Beroud, G., Akiyama, T., Abifadel, M., Harada, N., Morisaki, T. et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet 36, 855\u2013860 (2004).","journal-title":"Nat. Genet"},{"key":"BFjhg2015119_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI69942","volume":"124","author":"W Li","year":"2014","unstructured":"Li, W., Li, Q., Jiao, Y., Qin, L., Ali, R., Zhou, J. et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J. Clin. Invest. 124, 755\u2013767 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFjhg2015119_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/jmedgenet-2011-100382","volume":"49","author":"IM van de Laar","year":"2012","unstructured":"van de Laar, I. M., van der Linde, D., Oei, E. H., Bos, P. K., Bessems, J. H., Bierma-Zeinstra, S. M. et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J. Med. Genet. 49, 47\u201357 (2012).","journal-title":"J. Med. Genet."},{"key":"BFjhg2015119_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/ng.2348","volume":"44","author":"C Boileau","year":"2012","unstructured":"Boileau, C., Guo, D. C., Hanna, N., Regalado, E. S., Detaint, D., Gong, L. et al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat. Genet. 44, 916\u2013921 (2012).","journal-title":"Nat. Genet."},{"key":"BFjhg2015119_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/ng.2349","volume":"44","author":"ME Lindsay","year":"2012","unstructured":"Lindsay, M. E., Schepers, D., Bolar, N. A., Doyle, J. J., Gallo, E., Fert-Bober, J. et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat. Genet. 44, 922\u2013927 (2012).","journal-title":"Nat. Genet."},{"key":"BFjhg2015119_CR23","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2015.01.040","volume":"65","author":"AM Bertoli-Avella","year":"2015","unstructured":"Bertoli-Avella, A. M., Gillis, E., Morisaki, H., Verhagen, J. M. A., de Graaf, B. M., van de Beek, G. et al. Mutations in a TGF\u03b2 ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J. Am. Coll. Cardiol. 65, 1324\u20131336 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFjhg2015119_CR24","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/ajmg.a.36056","volume":"161A","author":"HY Rienhoff Jr","year":"2013","unstructured":"Rienhoff, H. Y. Jr, Yeo, C. Y., Morissette, R., Khrebtukova, I., Melnick, J., Luo, S. et al. A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome. Am. J. Med. Genet. 161A, 2040\u20132046 (2013).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2015119_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1172\/JCI61498","volume":"122","author":"J Iwata","year":"2012","unstructured":"Iwata, J., Hacia, J. G., Suzuki, A., Sanchez-Lara, P. A., Urata, M. & Chai, Y. Modulation of noncanonical TGF-\u03b2 signaling prevents cleft palate in Tgfbr2 mutant mice. J. Clin. Invest. 122, 873\u2013885 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFjhg2015119_CR26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2421","volume":"44","author":"AJ Doyle","year":"2012","unstructured":"Doyle, A. J., Doyle, J. J., Bessling, S. L., Maragh, S., Lindsay, M. E., Schepers, D. et al. Mutations in the TGF-\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat. Genet. 44, 1249\u20131254 (2012).","journal-title":"Nat. Genet."},{"key":"BFjhg2015119_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ejhg.2010.45","volume":"18","author":"M Renard","year":"2010","unstructured":"Renard, M., Holm, T., Veith, R., Callewaert, B. L., Ad\u00e8s, L. C., Baspinar, O. et al. Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur. J. Hum. Genet. 18, 895\u2013901 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFjhg2015119_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCRESAHA.109.207852","volume":"106","author":"J Huang","year":"2010","unstructured":"Huang, J., Davis, E. C., Chapman, S. L., Budatha, M., Marmorstein, L.Y, Word, R. A. et al. Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ. Res. 106, 583\u2013592 (2010).","journal-title":"Circ. Res."},{"key":"BFjhg2015119_CR29","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1016\/S0021-9258(18)68776-9","volume":"263","author":"A Superti-Furga","year":"1988","unstructured":"Superti-Furga, A., Gugler, E., Gitzelmann, R. & Steinmann, B. Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J. Biol. Chem. 263, 6226\u20136232 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFjhg2015119_CR30","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/S0140-6736(10)60960-9","volume":"376","author":"KT Ong","year":"2010","unstructured":"Ong, K. T., Perdu, J., De Backer, J., Bozec, E., Collignon, P., Emmerich, J. et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 376, 1476\u20131484 (2010).","journal-title":"Lancet"},{"key":"BFjhg2015119_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1212\/01.WNL.0000149512.79621.DF","volume":"64","author":"VL Sheen","year":"2005","unstructured":"Sheen, V. L., Jansen, A., Chen, M. H., Parrini, E., Morgan, T., Ravenscroft, R. et al. Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology 64, 254\u2013262 (2005).","journal-title":"Neurology"},{"key":"BFjhg2015119_CR32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0896-6273(00)80651-0","volume":"21","author":"JW Fox","year":"1998","unstructured":"Fox, J. W., Lamperti, E. D., Ek\u015fio\u011flu, Y. Z., Hong, S. E., Feng, Y., Graham, D. A. et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21, 1315\u20131325 (1998).","journal-title":"Neuron"},{"key":"BFjhg2015119_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H. et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465\u2013468 (2001).","journal-title":"Nat. Genet."},{"key":"BFjhg2015119_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","volume":"249","author":"MR Wallace","year":"1990","unstructured":"Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M. et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181\u2013186 (1990).","journal-title":"Science"},{"key":"BFjhg2015119_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ng0797-235","volume":"16","author":"T Oda","year":"1997","unstructured":"Oda, T., Elkahloun, A. G., Pike, B. L., Okajima, K., Krantz, I. D., Genin, A. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet 16, 235\u2013242 (1997).","journal-title":"Nat. Genet"},{"key":"BFjhg2015119_CR36","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(80)92675-6","volume":"1","author":"AP Roodvoets","year":"1980","unstructured":"Roodvoets, A. P. Aortic aneurysms in presence of kidney disease. Lancet 1, 1413\u20131414 (1980).","journal-title":"Lancet"},{"key":"BFjhg2015119_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/ng.2007.6","volume":"39","author":"DC Guo","year":"2007","unstructured":"Guo, D. C., Pannu, H., Tran-Fadulu, V., Papke, C. L., Yu, R. K., Avidan, N. et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39, 1488\u20131493 (2007).","journal-title":"Nat. Genet."},{"key":"BFjhg2015119_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","volume":"84","author":"DC Guo","year":"2009","unstructured":"Guo, D. C., Papke, C. L., Tran-Fadulu, V., Regalado, E. S., Avidan, N., Johnson, R. J. et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am. J. Hum. Genet. 84, 617\u2013627 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2015119_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpn.2010.09.002","volume":"15","author":"C Roder","year":"2011","unstructured":"Roder, C., Peters, V., Kasuya, H., Nishizawa, T., Wakita, S., Berg, D. et al. Analysis of ACTA2 in European Moyamoya disease patients. Eur. J. Paediatr. Neurol. 15, 117\u2013122 (2011).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"BFjhg2015119_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ng1721","volume":"38","author":"L Zhu","year":"2006","unstructured":"Zhu, L., Vranckx, R., Khau Van Kien, P., Lalande, A., Boisset, N., Mathieu, F. et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus. Nat. Genet. 38, 343\u2013349 (2006).","journal-title":"Nat. Genet."},{"key":"BFjhg2015119_CR41","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajhg.2010.10.006","volume":"87","author":"L Wang","year":"2010","unstructured":"Wang, L., Guo, D. C., Cao, J., Gong, L., Kamm, K. E., Regalado, E. et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am. J. Hum. Genet. 87, 701\u2013707 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2015119_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijcard.2011.08.079","volume":"165","author":"M Renard","year":"2013","unstructured":"Renard, M., Callewaert, B., Baetens, M., Campens, L., MacDermot, K., Fryns, J. P. et al. Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF\u03b2 signaling in FTAAD. Int. J. Cardiol. 165, 314\u2013321 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFjhg2015119_CR43","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.jacc.2010.02.015","volume":"55","author":"LF Hiratzka","year":"2010","unstructured":"Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E. Jr et al. 2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: a Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J. Am. Coll. Cardiol. 55, e27\u2013e129 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFjhg2015119_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117\u2013121 (2006).","journal-title":"Science"},{"key":"BFjhg2015119_CR45","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","volume":"358","author":"BS Brooke","year":"2008","unstructured":"Brooke, B. S., Habashi, J. P., Judge, D. P., Patel, N., Loeys, B. & Dietz, H. C. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 358, 2787\u20132795 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg2015119_CR46","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro, R. V., Dietz, H. C., Sleeper, L. A., Yetman, A. T., Bradley, T. J., Colan, S. D. et al. Atenolol versus losartan in children and young adults with Marfan's syndrome. N. Engl. J. Med. 371, 2061\u20132071 (2014).","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg2015119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2015119","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2015119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:33:45Z","timestamp":1684431225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg2015119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFjhg2015119"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2015.119","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]},"assertion":[{"value":"24 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}